108
Participants
Start Date
March 16, 2020
Primary Completion Date
January 20, 2021
Study Completion Date
February 20, 2021
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Intramuscular other name:Ad5-nCoV
Hubei Provincial Center for Disease Control and Prevention, Wuhan
Lead Sponsor
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
OTHER
Jiangsu Province Centers for Disease Control and Prevention
NETWORK
Hubei Provincial Center for Disease Control and Prevention
OTHER
Tongji Hospital
OTHER
CanSino Biologics Inc.
INDUSTRY